Evolved bacterial resistance to the chemotherapy gemcitabine modulates its efficacy

Serkan Sayin(University of Massachusetts Chan Medical School), Amir Mitchell(University of Massachusetts Chan Medical School), Carmen G Li(University of Massachusetts Chan Medical School), Doyle V. Ward(University of Massachusetts Chan Medical School), Brittany Rosener(University of Massachusetts Chan Medical School), Bao Ho(University of Massachusetts Chan Medical School), Albertha J.M. Walhout(University of Massachusetts Chan Medical School), Olga Ponomarova(University of Massachusetts Chan Medical School)
bioRxiv (Cold Spring Harbor Laboratory)
September 7, 2022
10.1101/2022.09.07.506952
Cited by 1

Related Papers

Structure, function and diversity of the healthy human microbiome
|Nature|2012|12k
Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons
|Genome Research|2011|3.6k
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
|Genome biology|2012|2.8k
Determination and Inference of Eukaryotic Transcription Factor Sequence Specificity
|Cell|2014|2k
Evidence for dynamically organized modularity in the yeast protein–protein interaction network
|Nature|2004|1.8k